Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease - PubMed (original) (raw)
Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease
Howard J Federoff. Neurotox Res. 2009 Oct.
Abstract
The canonical histopathological feature of Parkinson's disease (PD) is the loss of dopaminergic neurons in the ventral midbrain. Although the common sporadic/idiopathic form of PD most often presents clinically at around 60 years of age when the levels of striatal dopamine and numbers of ventral dopaminergic neurons are posited to have declined by 80 and 60%, respectively, the temporal pattern of injury to these vulnerable cells is unknown. The conventional view is that PD results from an accelerated age-related loss of dopamine neurons. However, an alternative hypothesis is that dopamine neuron loss is a developmental phenomenon. What evidence might support this alternative view? Apart from the rare familial forms, wherein loss or gain of function mutations in single genes convey highly penetrant PD, sporadic disease is genetically complex and may have other contributory non-genetic components. Epidemiologic and twin studies have strongly implicated gene-environmental interaction as a pathogenic dyad in the etiology of PD. Among the most attractive candidates that may connect the environment to inherited vulnerability is the nuclear receptor, Nurr1. Encoding an orphan transcription factor that is expressed at high levels within discrete regions of the developing and adult mammalian brain, Nurr1 is essential for the formation of ventral midbrain dopamine neurons. Given the absence of a known lipophilic small molecule regulator and established transcriptional role in the formation of the definitive dopaminergic phenotype, Nurr1 represents an intriguing molecule to explore in the context of sporadic PD as a developmental disorder. The study described herein addresses two features of Nurr1 biology that provide plausibility for this hypothesis. First is the description of Nurr1 regulation of a potent dopaminergic neuronal trophic factor, vasoactive intestinal peptide (VIP), and second is the identification of a protein, termed Nurr1 interacting protein (NuIP) that appears to link upstream signaling pathways in the regulation of Nurr1 transcriptional activity.
Similar articles
- VIP is a transcriptional target of Nurr1 in dopaminergic cells.
Luo Y, Henricksen LA, Giuliano RE, Prifti L, Callahan LM, Federoff HJ. Luo Y, et al. Exp Neurol. 2007 Jan;203(1):221-32. doi: 10.1016/j.expneurol.2006.08.005. Epub 2006 Sep 26. Exp Neurol. 2007. PMID: 16999955 - The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.
Jankovic J, Chen S, Le WD. Jankovic J, et al. Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38. doi: 10.1016/j.pneurobio.2005.09.001. Epub 2005 Oct 21. Prog Neurobiol. 2005. PMID: 16243425 Review. - The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival.
Luo Y. Luo Y. Int Rev Neurobiol. 2012;102:1-22. doi: 10.1016/B978-0-12-386986-9.00001-6. Int Rev Neurobiol. 2012. PMID: 22748824 Review. - Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation.
Witta J, Baffi JS, Palkovits M, Mezey E, Castillo SO, Nikodem VM. Witta J, et al. Brain Res Mol Brain Res. 2000 Dec 8;84(1-2):67-78. doi: 10.1016/s0169-328x(00)00211-4. Brain Res Mol Brain Res. 2000. PMID: 11113533 - NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.
Decressac M, Volakakis N, Björklund A, Perlmann T. Decressac M, et al. Nat Rev Neurol. 2013 Nov;9(11):629-36. doi: 10.1038/nrneurol.2013.209. Epub 2013 Oct 15. Nat Rev Neurol. 2013. PMID: 24126627 Review.
Cited by
- Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.
Maguire-Zeiss KA, Federoff HJ. Maguire-Zeiss KA, et al. J Neural Transm (Vienna). 2010 Aug;117(8):1019-25. doi: 10.1007/s00702-010-0431-6. Epub 2010 Jun 12. J Neural Transm (Vienna). 2010. PMID: 20549523 Review. - Effects of Postnatal Enriched Environment in a Model of Parkinson's Disease in Adult Rats.
Jungling A, Reglodi D, Karadi ZN, Horvath G, Farkas J, Gaszner B, Tamas A. Jungling A, et al. Int J Mol Sci. 2017 Feb 14;18(2):406. doi: 10.3390/ijms18020406. Int J Mol Sci. 2017. PMID: 28216584 Free PMC article. - Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Guo C, Sun L, Chen X, Zhang D. Guo C, et al. Neural Regen Res. 2013 Jul 25;8(21):2003-14. doi: 10.3969/j.issn.1673-5374.2013.21.009. Neural Regen Res. 2013. PMID: 25206509 Free PMC article. Review. - Exposure to atrazine during gestation and lactation periods: toxicity effects on dopaminergic neurons in offspring by downregulation of Nurr1 and VMAT2.
Sun Y, Li YS, Yang JW, Yu J, Wu YP, Li BX. Sun Y, et al. Int J Mol Sci. 2014 Feb 18;15(2):2811-25. doi: 10.3390/ijms15022811. Int J Mol Sci. 2014. PMID: 24552878 Free PMC article. - RUTBC2 protein, a Rab9A effector and GTPase-activating protein for Rab36.
Nottingham RM, Pusapati GV, Ganley IG, Barr FA, Lambright DG, Pfeffer SR. Nottingham RM, et al. J Biol Chem. 2012 Jun 29;287(27):22740-8. doi: 10.1074/jbc.M112.362558. Epub 2012 May 25. J Biol Chem. 2012. PMID: 22637480 Free PMC article.
References
- Ann Neurol. 1998 Sep;44(3 Suppl 1):S115-20 - PubMed
- Curr Protein Pept Sci. 2002 Aug;3(4):423-39 - PubMed
- Science. 1983 Feb 25;219(4587):979-80 - PubMed
- Behav Brain Res. 2002 Oct 17;136(1):317-24 - PubMed
- Mol Endocrinol. 1992 Dec;6(12):2129-35 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical